Other Operating Expenses - Maat Pharma SA (PAR:MAAT) - Alpha Spread
M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 7.3 EUR 2.24% Market Closed
Market Cap: 101.4m EUR
Have any thoughts about
Maat Pharma SA?
Write Note

Maat Pharma SA
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Maat Pharma SA
Other Operating Expenses Peer Comparison

Comparables:
VLA
NANO
IPH
GNFT
ALERS

Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
M
Maat Pharma SA
PAR:MAAT
Other Operating Expenses
€4.7m
CAGR 3-Years
30%
CAGR 5-Years
39%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Other Operating Expenses
€20m
CAGR 3-Years
-7%
CAGR 5-Years
30%
CAGR 10-Years
14%
Nanobiotix SA
PAR:NANO
Other Operating Expenses
€3.6m
CAGR 3-Years
14%
CAGR 5-Years
1%
CAGR 10-Years
10%
Innate Pharma SA
PAR:IPH
Other Operating Expenses
€6.4m
CAGR 3-Years
-22%
CAGR 5-Years
-8%
CAGR 10-Years
3%
Genfit SA
NASDAQ:GNFT
Other Operating Expenses
-€16.6m
CAGR 3-Years
-9%
CAGR 5-Years
-6%
CAGR 10-Years
-7%
Eurobio Scientific SA
PAR:ALERS
Other Operating Expenses
€643k
CAGR 3-Years
25%
CAGR 5-Years
4%
CAGR 10-Years
-1%

See Also

What is Maat Pharma SA's Other Operating Expenses?
Other Operating Expenses
4.7m EUR

Based on the financial report for Dec 31, 2023, Maat Pharma SA's Other Operating Expenses amounts to 4.7m EUR.

What is Maat Pharma SA's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
39%

Over the last year, the Other Operating Expenses growth was 13%. The average annual Other Operating Expenses growth rates for Maat Pharma SA have been 30% over the past three years , 39% over the past five years .

Back to Top